Reply

Affiliations

Comment

Matthew A Rutherford et al. Arthritis Rheumatol. 2022 Apr.

. 2022 Apr;74(4):725-726.

doi: 10.1002/art.42024. Epub 2022 Feb 21.

No abstract available

Comment on

Risk Factors for Severe Outcomes in Patients With Systemic Vasculitis and COVID-19: A Binational, Registry-Based Cohort Study.
Rutherford MA, Scott J, Karabayas M, Antonelou M, Gopaluni S, Gray D, Barrett J, Brix SR, Dhaun N, McAdoo SP, Smith RM, Geddes CC, Jayne D, Luqmani R, Salama AD, Little MA, Basu N; UK and Ireland Vasculitis Rare Disease Group (UKIVAS). Rutherford MA, et al. Arthritis Rheumatol. 2021 Sep;73(9):1713-1719. doi: 10.1002/art.41728. Epub 2021 Jul 27. Arthritis Rheumatol. 2021. PMID: 33750043 Free PMC article.
Factors influencing severe COVID-19 in systemic vasculitis patients: comment on the article by Rutherford et al.
Kardaş RC, Küçük H. Kardaş RC, et al. Arthritis Rheumatol. 2022 Apr;74(4):725. doi: 10.1002/art.42022. Epub 2022 Feb 21. Arthritis Rheumatol. 2022. PMID: 34783170 Free PMC article. No abstract available.

1. Mukhtyar C, Lee R, Brown D, Carruthers D, Dasgupta B, Dubey S, et al. Modification and validation of the Birmingham Vasculitis Activity Score (version 3). Ann Rheum Dis 2009;68:1827–32. - PubMed